Table 3 Participant withdrawal criteria of the Sipjeondaebo-tang study
Participant withdrawal criterion | |
|---|---|
1. Those whose medication compliance is < 70% | |
2. Those who become pregnant during the study period | |
3. Those who need surgery or inpatient treatment due to emergencies such as accidents or other illnesses | |
4. Subject’s withdrawal of consent | |
5. Subjects who have received prohibited medicines or therapies (e.g., anticoagulants, psychotropic drugs, and other drugs that may affect the symptoms of CHHF) | |
6. Those who need standard treatment due to deterioration of symptoms of CHHF | |
7. Occurrence of a serious adverse event | |
8. Occurrence of factors making it difficult to sustain the process or investigator’s decision to terminate because of clinical trial results affected by some factors |